Published in Br J Cancer on March 13, 2007
Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma. Br J Cancer (2007) 2.09
A review of clinical and molecular prognostic factors in osteosarcoma. J Cancer Res Clin Oncol (2007) 2.07
CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer. Br J Cancer (2008) 1.93
SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer. J Clin Invest (2012) 1.71
Lymphangiogenesis and lymphatic metastasis in breast cancer. Pathophysiology (2009) 1.48
Lymphangiogenesis induced by VEGF-C and VEGF-D promotes metastasis and a poor outcome in breast carcinoma: a retrospective study of 61 cases. Clin Exp Metastasis (2008) 1.17
Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients. Breast Cancer Res (2009) 1.16
Lymphangiogenesis and cancer. Genes Cancer (2011) 1.16
Met synergizes with p53 loss to induce mammary tumors that possess features of claudin-low breast cancer. Proc Natl Acad Sci U S A (2013) 1.14
Overexpression of both VEGF-A and VEGF-C in gastric cancer correlates with prognosis, and silencing of both is effective to inhibit cancer growth. Int J Clin Exp Pathol (2013) 1.13
Recombinant human endostatin endostar suppresses angiogenesis and lymphangiogenesis of malignant pleural effusion in mice. PLoS One (2012) 1.00
Hypoxia increases breast cancer cell-induced lymphatic endothelial cell migration. Neoplasia (2008) 1.00
The role of the VEGF-C/VEGFRs axis in tumor progression and therapy. Int J Mol Sci (2012) 0.97
Preoperative serum levels of serum VEGF-C is associated with distant metastasis in colorectal cancer patients. Int J Colorectal Dis (2008) 0.93
Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases. BMC Cancer (2010) 0.92
Prognostic significance of vascular endothelial growth factor expression in gastric carcinoma: a meta-analysis. J Cancer Res Clin Oncol (2011) 0.92
ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis. EMBO Mol Med (2013) 0.92
Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients. World J Surg Oncol (2012) 0.91
The role of lymphangiogenesis and angiogenesis in tumor metastasis. Cell Oncol (Dordr) (2016) 0.89
Vascular endothelial growth factor expression in ovarian serous carcinomas and its effect on tumor proliferation. South Asian J Cancer (2013) 0.89
Dietary fat alters pulmonary metastasis of mammary cancers through cancer autonomous and non-autonomous changes in gene expression. Clin Exp Metastasis (2010) 0.88
Lymphatic metastasis in breast cancer: importance and new insights into cellular and molecular mechanisms. Clin Exp Metastasis (2007) 0.87
Vascular endothelial growth factor C promotes breast cancer progression via a novel antioxidant mechanism that involves regulation of superoxide dismutase 3. Breast Cancer Res (2014) 0.87
Vascular endothelial growth factor-C induces lymphangitic carcinomatosis, an extremely aggressive form of lung metastases. Cancer Res (2010) 0.86
Protein expression changes during human triple negative breast cancer cell line progression to lymph node metastasis in a xenografted model in nude mice. Cancer Biol Ther (2012) 0.86
Histopathological subclassification of triple negative breast cancer using prognostic scoring system: five variables as candidates. Virchows Arch (2010) 0.84
Co-expression of α9β1 integrin and VEGF-D confers lymphatic metastatic ability to a human breast cancer cell line MDA-MB-468LN. PLoS One (2012) 0.84
RASSF8 downregulation promotes lymphangiogenesis and metastasis in esophageal squamous cell carcinoma. Oncotarget (2015) 0.84
Relationships between Lymph Node Metastasis and Expression of CD31, D2-40, and Vascular Endothelial Growth Factors A and C in Papillary Thyroid Cancer. Clin Exp Otorhinolaryngol (2012) 0.84
Role of lymphatic vasculature in regional and distant metastases. Microvasc Res (2014) 0.83
MT1-MMP in breast cancer: induction of VEGF-C correlates with metastasis and poor prognosis. Cancer Cell Int (2013) 0.83
VEGF-C-VEGFR3/Flt4 axis regulates mammary tumor growth and metastasis in an autocrine manner. Am J Cancer Res (2015) 0.83
Lymphangiogenesis and lymph node metastasis in breast cancer. Mol Cancer (2008) 0.81
Impact of breast cancer surgery on angiogenesis circulating biomarkers: a prospective longitudinal study. World J Surg Oncol (2013) 0.81
VEGF-D-induced draining lymphatic enlargement and tumor lymphangiogenesis promote lymph node metastasis in a xenograft model of ovarian carcinoma. Reprod Biol Endocrinol (2014) 0.80
Molecular pathways of lymphangiogenesis and lymph node metastasis in head and neck cancer. Eur Arch Otorhinolaryngol (2011) 0.80
Inhibition of TGFBIp expression reduces lymphangiogenesis and tumor metastasis. Oncogene (2015) 0.80
Changing molecular profile of brain metastases compared with matched breast primary cancers and impact on clinical outcomes. Br J Cancer (2016) 0.80
In vivo "MRI phenotyping" reveals changes in extracellular matrix transport and vascularization that mediate VEGF-driven increase in breast cancer metastasis. PLoS One (2013) 0.79
Hydrophobic Fractionation Enhances Novel Protein Detection by Mass Spectrometry in Triple Negative Breast Cancer. J Proteomics Bioinform (2010) 0.79
Angiotensin II type 1 receptor (AT-1R) expression correlates with VEGF-A and VEGF-D expression in invasive ductal breast cancer. Pathol Oncol Res (2012) 0.78
Both high expression of pyruvate kinase M2 and vascular endothelial growth factor-C predicts poorer prognosis in human breast cancer. Int J Clin Exp Pathol (2015) 0.78
Characterization of human multicentric osteosarcoma using newly established cells derived from multicentric osteosarcoma. J Cancer Res Clin Oncol (2010) 0.78
Breast Tumor Angiogenesis and Tumor-Associated Macrophages: Histopathologist's Perspective. Patholog Res Int (2011) 0.78
(Lymph)angiogenic influences on hematopoietic cells in acute myeloid leukemia. Exp Mol Med (2014) 0.78
Anti-angiogenic efficacy of 5'-triphosphate siRNA combining VEGF silencing and RIG-I activation in NSCLCs. Oncotarget (2015) 0.77
Disrupting VEGF-A paracrine and autocrine loops by targeting SHP-1 suppresses triple negative breast cancer metastasis. Sci Rep (2016) 0.77
miRNome of inflammatory breast cancer. BMC Res Notes (2014) 0.77
The non-canonical role of vascular endothelial growth factor-C axis in cancer progression. Exp Biol Med (Maywood) (2015) 0.77
A novel cell-penetrating peptide suppresses breast tumorigenesis by inhibiting β-catenin/LEF-1 signaling. Sci Rep (2016) 0.76
Comparison of angiogenesis-related factor expression in primary tumor cultures under normal and hypoxic growth conditions. Cancer Cell Int (2008) 0.76
Immunostaining with D2-40 improves evaluation of lymphovascular invasion, but may not predict sentinel lymph node status in early breast cancer. BMC Cancer (2009) 0.76
SIRT1 expression is associated with lymphangiogenesis, lymphovascular invasion and prognosis in pN0 esophageal squamous cell carcinoma. Cell Biosci (2014) 0.76
Lymphangiogenesis and Axillary Lymph Node Metastases Correlated with VEGF-C Expression in Two Immunocompetent Mouse Mammary Carcinoma Models. Int J Breast Cancer (2011) 0.75
A small interfering RNA targeting vascular endothelial growth factor efficiently inhibits growth of VX2 cells and VX2 tumor model of hepatocellular carcinoma in rabbit by transarterial embolization-mediated siRNA delivery. Drug Des Devel Ther (2016) 0.75
Prognostic Significance of High VEGF-C Expression for Patients with Breast Cancer: An Update Meta Analysis. PLoS One (2016) 0.75
Lymphangiogenesis in breast cancer is associated with non-sentinel lymph node metastases in sentinel node positive patients. Int J Clin Exp Pathol (2015) 0.75
Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N Engl J Med (1991) 19.46
The biology of vascular endothelial growth factor. Endocr Rev (1997) 13.70
Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol (2004) 10.55
Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst (1992) 8.69
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med (2001) 7.78
Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science (1997) 6.37
VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med (2001) 5.52
Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J (2001) 4.70
Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol (2005) 3.21
Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med (2002) 3.16
Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol (1993) 2.85
VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol (1997) 2.43
VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the alpha1beta1 and alpha2beta1 integrins. FASEB J (2004) 2.27
Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature. Br J Cancer (2006) 2.11
Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin Cancer Res (1999) 2.03
A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J (1996) 1.95
Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. Clin Cancer Res (2000) 1.80
Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. Genomics (1997) 1.75
Expression of vascular endothelial growth factor D is associated with hypoxia inducible factor (HIF-1alpha) and the HIF-1alpha target gene DEC1, but not lymph node metastasis in primary human breast carcinomas. J Clin Pathol (2004) 1.72
Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res Treat (1995) 1.67
Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis. Ann Surg Oncol (2001) 1.58
Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis. Prostate (2005) 1.56
Histological quantitation of tumour angiogenesis. APMIS (2004) 1.52
Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer. Breast Cancer Res Treat (2005) 1.47
Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma. Cancer Res (2002) 1.47
Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma. Cancer Sci (2004) 1.41
Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugs. Lancet Oncol (2001) 1.36
Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression. Mod Pathol (2005) 1.34
Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis. Cancer (2001) 1.30
Clinicopathological significance of vascular endothelial growth factor-C in breast carcinoma with long-term follow-up. Mod Pathol (2003) 1.20
Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer. Clin Cancer Res (1995) 1.18
Prognostic significance of vascular endothelial growth factor D in breast carcinoma with long-term follow-up. Clin Cancer Res (2003) 1.18
Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro. Angiogenesis (2005) 1.16
Expression of vascular endothelial growth factor (VEGF)-D and its receptor, VEGF receptor 3, as a prognostic factor in endometrial carcinoma. Clin Cancer Res (2003) 1.15
Changes in the extracellular matrix of the normal human breast during the menstrual cycle. Cell Tissue Res (1992) 1.14
The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers. Clin Cancer Res (2000) 1.13
Vascular endothelial growth factor, a specific regulator of angiogenesis. Curr Opin Nephrol Hypertens (1996) 1.12
Role of VEGF-C and VEGF-D in lymphangiogenesis in gastric cancer. Int J Clin Oncol (2005) 1.11
Prox1 is a marker of ectodermal placodes, endodermal compartments, lymphatic endothelium and lymphangioblasts. Anat Embryol (Berl) (2001) 1.06
ErbB2 overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human breast carcinoma. Cancer (2002) 1.06
Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer. Int J Oncol (2005) 1.06
Lymphatic vessel density is significantly increased in melanoma. J Cutan Pathol (2004) 1.03
Accelerated lymphangiogenesis in malignant lymphoma: possible role of VEGF-A and VEGF-C. Br J Haematol (2005) 0.98
The use of LYVE-1 antibody for detecting lymphatic involvement in patients with malignant melanoma of known sentinel node status. J Clin Pathol (2005) 0.98
VEGF expression is associated with negative estrogen receptor status in patients with breast cancer. Int J Surg Pathol (2006) 0.97
Does vascular endothelial growth factor (VEGF) predict local relapse and survival in radiotherapy-treated node-negative breast cancer? Br J Cancer (1999) 0.95
Prognostic value of intratumoral microvessel density, a measure of tumor angiogenesis, in node-negative breast carcinoma--results of a multiparametric study. Breast Cancer Res Treat (1995) 0.95
Vascular endothelial growth factor-C and vascular endothelial growth factor-d messenger RNA expression in breast cancer: association with lymph node metastasis. Clin Breast Cancer (2003) 0.92
Lymphatic versus blood vascular endothelial growth factors and receptors in humans. Microsc Res Tech (2001) 0.92
Prognostic significance of vascular endothelial growth factor D in gastric carcinoma. World J Surg (2005) 0.92
Clinical significance of VEGF-A, -C and -D expression in esophageal malignancies. Onkologie (2005) 0.90
Hormonal variations in the vascularity of breast tissue. J Ultrasound Med (2005) 0.84
Lymphatic vessel density in vocal cord carcinomas assessed with LYVE-1 receptor expression. Radiother Oncol (2005) 0.78
[Expression of vascular endothelial growth factor A and C in human breast cancer and their significance]. Ai Zheng (2005) 0.77
Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology (1991) 30.87
The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat (1992) 6.51
Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature (1998) 5.59
Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst (1989) 3.48
Confirmation of a prognostic index in primary breast cancer. Br J Cancer (1987) 3.29
A gene-expression signature to predict survival in breast cancer across independent data sets. Oncogene (2006) 3.21
Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centres. J Pathol (2003) 3.14
Mutation of yeast Ku genes disrupts the subnuclear organization of telomeres. Curr Biol (1998) 3.13
Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood (2001) 2.99
Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med (1987) 2.98
Gestational diabetes mellitus in India. J Assoc Physicians India (2004) 2.86
Trends in childhood type 1 diabetes incidence in Europe during 1989-2008: evidence of non-uniformity over time in rates of increase. Diabetologia (2012) 2.85
Factors influencing local recurrence after excision and radiotherapy for primary breast cancer. Br J Surg (1989) 2.84
Expression of T cell antigen receptor heterodimers in a lipid-linked form. Science (1990) 2.56
Familiarity with and social distance from people who have serious mental illness. Psychiatr Serv (2001) 2.47
Buteyko breathing techniques in asthma: a blinded randomised controlled trial. Med J Aust (1999) 2.42
Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twins. BMJ (1995) 2.40
Neuroendocrine differentiation and prognosis in breast adenocarcinoma. Histopathology (2002) 2.35
Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nat Med (2001) 2.26
Neonatal screening for inborn errors of metabolism: cost, yield and outcome. Health Technol Assess (1997) 2.20
Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. J Intern Med (1999) 2.19
CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology (2006) 2.19
Sentinel node biopsy for breast cancer may have little to offer four-node-samplers. results of a prospective comparison study. Eur J Cancer (2001) 2.16
N-acetylcysteine replenishes glutathione in HIV infection. Eur J Clin Invest (2000) 2.13
Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women. J Clin Endocrinol Metab (1999) 2.13
The importance of genes and environment for ocular refraction and its determiners: a population based study among 20-45 year old twins. Br J Ophthalmol (2001) 2.09
The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. J Clin Endocrinol Metab (1995) 2.07
Cause of death and correlation with autopsy findings in burns patients. Burns (2012) 2.07
Epidemiological studies of diabetes mellitus in Denmark. II. A prevalence study based on insulin prescriptions. Diabetologia (1981) 2.06
Molecular characteristics and prognostic features of breast cancer in Nigerian compared with UK women. Breast Cancer Res Treat (2012) 2.05
Tolerance of nicotinamide and carbogen with radiation therapy for glioblastoma. Radiother Oncol (1996) 2.03
Health sector reform and the interpretation of policy context. Health Policy (1999) 2.00
Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950-1974. Acta Med Scand (1980) 1.98
Further evidence for an association between genetic variation in transforming growth factor alpha and cleft lip and palate. Am J Hum Genet (1991) 1.98
Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma. Br J Cancer (2004) 1.97
Ki67 immunostaining in primary breast cancer: pathological and clinical associations. Br J Cancer (1989) 1.97
Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation. J Pathol (2006) 1.97
Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn's disease. Gut (2002) 1.96
Prejudice, social distance, and familiarity with mental illness. Schizophr Bull (2001) 1.95
Nail patella syndrome: a review of the phenotype aided by developmental biology. J Med Genet (2003) 1.95
Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999. Eur J Cancer (2007) 1.94
Phyllodes tumours of the breast: a clinicopathological review of thirty-two cases. Histopathology (1995) 1.90
Histologic grading of breast cancer: linkage of patient outcome with level of pathologist agreement. Mod Pathol (2000) 1.88
How much residual plasma may cause TRALI? Transfus Med (2008) 1.85
Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial. Eur J Cancer (2013) 1.85
Reading the prognosis of the individual with breast cancer. Eur J Cancer (2007) 1.83
Screening interval breast cancers: mammographic features and prognosis factors. Radiology (1996) 1.82
Beyond ovulation: oral contraceptives and epithelial ovarian cancer. Epidemiology (2000) 1.82
Review of the epidemiologic literature on EMF and Health. Environ Health Perspect (2001) 1.80
Risk analysis in the development of pterygia. Ophthalmology (1992) 1.79
Use of tumour marker immunoreactivity to identify primary site of metastatic cancer. BMJ (1993) 1.79
Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up. Histopathology (1994) 1.78
Idiopathic adhesive capsulitis. A prospective functional outcome study of nonoperative treatment. J Bone Joint Surg Am (2000) 1.78
Common acquired naevi and the risk of malignant melanoma. Int J Cancer (1985) 1.76
Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer. Endocr Relat Cancer (2005) 1.75
The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation (1996) 1.75
Decentralization and primary health care: some negative implications in developing countries. Int J Health Serv (1994) 1.75
The prognostic significance of B lymphocytes in invasive carcinoma of the breast. Breast Cancer Res Treat (2011) 1.74
HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods. J Clin Pathol (2011) 1.73
An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid identification of potential biomarkers. Bioinformatics (2002) 1.73
X-ray refraction effects: application to the imaging of biological tissues. Br J Radiol (2003) 1.73
A monoclonal antibody, NCRC-11, raised to human breast carcinoma. 1. Production and immunohistological characterization. Histopathology (1984) 1.72
Cytological grading of breast carcinoma--a feasible proposition? Cytopathology (1990) 1.70
Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies. The International Melanoma Analysis Group (IMAGE). Int J Cancer (1995) 1.68
Melanocytic lesions excised from the skin: what percentage are malignant? Aust J Public Health (1994) 1.67
Identification of non-heme diiron proteins that catalyze triple bond and epoxy group formation. Science (1998) 1.67
Biopterin derivatives in normal and phenylketonuric patients after oral loads of L-phenylalanine, L-tyrosine, and L-tryptophan. Arch Dis Child (1976) 1.66
Prevalence of K329E mutation in medium-chain acyl-CoA dehydrogenase gene determined from Guthrie cards. Lancet (1991) 1.66
Is childhood-onset type I diabetes a wealth-related disease? An ecological analysis of European incidence rates. Diabetologia (2001) 1.66
Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer. Int J Cancer (2001) 1.65
The impact of core-biopsy on pre-operative diagnosis rate of screen detected breast cancers. Clin Radiol (1996) 1.64
Studies of the HLA system and insulin-dependent diabetes mellitus. Diabetes Care (1980) 1.63
Agonist control of G-protein levels. Trends Pharmacol Sci (1991) 1.63
Comparative pupil dilation using phenylephrine alone or in combination with tropicamide. Ophthalmology (1998) 1.61
A study of patient satisfaction and adherence to preventive care practice guidelines. Am J Med (1995) 1.60
A study of sweat sodium and chloride; criteria for the diagnosis of cystic fibrosis. Ann Clin Biochem (1985) 1.60
Monitoring the international use of unrelated donors for transplantation: the WMDA annual reports. Bone Marrow Transplant (2010) 1.60
Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival. Br J Cancer (1995) 1.60
Evaluation of eight and a half years of neonatal screening for haemoglobinopathies in Birmingham. Br Med J (Clin Res Ed) (1988) 1.59
CDKN2A variants in a population-based sample of Queensland families with melanoma. J Natl Cancer Inst (1999) 1.59
Screen detected ductal carcinoma in situ (DCIS): overdiagnosis or an obligate precursor of invasive disease? J Med Screen (2001) 1.58
Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression. Histopathology (2007) 1.57
Early-onset breast cancer--histopathological and prognostic considerations. Br J Cancer (1997) 1.56
A novel candidate region for ALS on chromosome 14q11.2. Neurology (2004) 1.56
Fecal shedding of Campylobacter and Arcobacter spp. in dairy cattle. Appl Environ Microbiol (2000) 1.56
The significance of lobular neoplasia on needle core biopsy of the breast. Virchows Arch (2008) 1.55
Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype. Br J Cancer (2008) 1.55
Consistency of histopathological reporting of breast lesions detected by screening: findings of the U.K. National External Quality Assessment (EQA) Scheme. U. K. National Coordinating Group for Breast Screening Pathology. Eur J Cancer (1994) 1.54
Helix pomatia and Ulex europeus lectin binding in human breast carcinoma. J Pathol (1987) 1.54
Regional variations in medium-chain acyl-CoA dehydrogenase deficiency. Lancet (1995) 1.52
Sunburn and malignant melanoma. Br J Cancer (1985) 1.51
The new Danish Twin Register: establishment and analysis of twinning rates. Int J Epidemiol (1995) 1.50
Fecal shedding of Salmonella spp. by dairy cows on farm and at cull cow markets. J Food Prot (2001) 1.50
Declining prevalence of STI in the London sex industry, 1985 to 2002. Sex Transm Infect (2004) 1.50
Systematic review: worldwide variation in the frequency of coeliac disease and changes over time. Aliment Pharmacol Ther (2013) 1.50
Vacuum-assisted excision of breast lesions of uncertain malignant potential (B3) - an alternative to surgery in selected cases. Breast (2008) 1.48